For years, experts have debated the evolving value proposition of higher education. But what do students think about it? To find out, The Chronicle partnered with Langer Research Associates to ...
The class of anti-inflammatory drugs known as TNF-inhibitors has brought relief to many sufferers of rheumatoid arthritis, but they don't work for up to 4 of every 10 patients. New research led by ...
The MarketWatch News Department was not involved in the creation of this content. AUSTIN, Texas, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Subcritical Systems Inc., an Austin-based energy technology company, ...
AUSTIN, Texas, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Subcritical Systems Inc., an Austin-based energy technology company, announced today that it plans to pursue licensing for its accelerator-driven ...
Please provide your email address to receive an email when new articles are posted on . Pegcetacoplan reduced proteinuria in patients with rare complement-mediated glomerular diseases vs. placebo.
Cedars-Sinai investigators have identified a genetic variant that increases people's risk of developing perianal Crohn's disease, the most debilitating manifestation of Crohn's disease. Science X ...
The complement system is an innate immune response that leads to increased inflammation. The drug pegcetacoplan—a complement inhibitor—was approved for medical use in the United States in 2021 to ...
Complement activation in immunological neurological disorders: mechanisms and therapeutic strategies
Recent advances in the understanding of immune-mediated neurological disorders have led to a paradigm shift toward pathophysiology-directed therapies. Central to this progress is a deeper appreciation ...
Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, China (H.C ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results